Patient 6 is heterozygous for a de novo mutation (c.1845T>C) in the gene GRIN2A, which encodes a member of the glutamate-gated ion channel protein family and is associated with focal epilepsy and mental retardation [57]. The gene discussed is GRIN2A; the disease is focal epilepsy.